Anzeige
Mehr »
Login
Samstag, 02.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
Technischer Ausbruch: Diese Kupferaktie ist in den letzten 52 Wochen um 300 % gestiegen! Der Durchbruch läuft!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2P723 | ISIN: KYG674111011 | Ticker-Symbol: 5DG
Frankfurt
01.11.24
08:05 Uhr
0,615 Euro
-0,010
-1,60 %
Branche
Pharma
Aktienmarkt
ASIEN
1-Jahres-Chart
OCUMENSION THERAPEUTICS Chart 1 Jahr
5-Tage-Chart
OCUMENSION THERAPEUTICS 5-Tage-Chart
RealtimeGeldBriefZeit
0,6300,68013:02
0,6100,69501.11.

Aktuelle News zur OCUMENSION THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrOCUMENSION-B (01477): NEXT DAY DISCLOSURE RETURN1
25.10.OCUMENSION-B (01477): NEXT DAY DISCLOSURE RETURN-
21.10.OCUMENSION-B (01477): LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION1
21.10.OCUMENSION-B (01477): RESIGNATION OF A NON-EXECUTIVE DIRECTOR-
16.10.OCUMENSION-B (01477): NEXT DAY DISCLOSURE RETURN1
16.10.OCUMENSION-B (01477): POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON OCTOBER 16, 20241
08.10.OCUMENSION-B (01477): NEXT DAY DISCLOSURE RETURN-
27.09.OCUMENSION-B (01477): CLOSURE OF REGISTER OF MEMBERS FOR THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON OCTOBER 16, 2024-
23.09.OCUMENSION-B (01477): VOLUNTARY ANNOUNCEMENT NEW DRUG APPLICATION OF OT-502 ACCEPTED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION2
19.09.OCUMENSION-B (01477): NEXT DAY DISCLOSURE RETURN-
19.09.OCUMENSION-B (01477): VOLUNTARY ANNOUNCEMENT NEW DRUG APPLICATION OF OT-1001 APPROVED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION1
17.09.OCUMENSION-B (01477): FURTHER DELAY IN DESPATCH OF CIRCULAR IN RELATION TO (1) VERY SUBSTANTIAL ACQUISITION IN RELATION TO ACQUISITION OF TRANSFERRED ...1
10.09.OCUMENSION-B (01477): 2024 INTERIM REPORT1
02.09.OCUMENSION-B (01477): DELAY IN DESPATCH OF CIRCULAR IN RELATION TO (1) VERY SUBSTANTIAL ACQUISITION IN RELATION TO ACQUISITION OF TRANSFERRED PRODUCTS, ...-
30.08.OCUMENSION-B (01477): NEXT DAY DISCLOSURE RETURN1
29.08.OCUMENSION-B (01477): NEXT DAY DISCLOSURE RETURN (RESUBMISSION)1
22.08.OCUMENSION-B (01477): NEXT DAY DISCLOSURE RETURN1
22.08.OCUMENSION-B (01477): VOLUNTARY ANNOUNCEMENT PROPOSED ON-MARKET SHARE REPURCHASE-
15.08.OCUMENSION-B (01477): NEXT DAY DISCLOSURE RETURN-
12.08.OcuMension Agrees To Acquire Rights Of Alcon Eye Drops In Exchange For 16.7% Equity Stake505WASHINGTON (dpa-AFX) - Ocumension Therapeutics, Monday announced an agreement to acquire commercialization rights of a Chinese portfolio of dry eye treatments and procedural drops of Alcon Inc....
► Artikel lesen
Seite:  Weiter >>
30 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1